One Health… One Drug… One Disease Model

The One Health concept is a global strategy for promoting comprehensive interdisciplinary and communications in all aspects of health care for humans, animals and the environment, this concept recognizes that the health of humans is intimately connected to the health of animals and the environment. We embrace this philosophy in our approach to antiviral and oncology drug development.  Learn More

Antiviral drug Development

Our first investigational product, is a novel peptide derived from natural sources. It is being evaluated for the treatment of viral infections in non-food animals (dogs, cats, horses and birds), in Vitro experimentation and data from pilot animal studies suggest that PVX demonstrates antiviral activity across a broad spectrum of virus families.

Oncology Drug Development

MMX is our secound investigational new drug. this formulation is being developed for the treatment of oral canine malignant melanoma stage II & III. in Vitro studies have demonstrated inhibition of cell proliferation in melanoma and treated with MMX, the subjects exhibited significant tumor reduction.

“this agreement exemplifies how Auburn university scientists, working with biotech and pharmaceutical industries, can provide expertise to move exciting new discoveries from the laboratory into the clinic.”

Dr. Bruce Smithprofessor, Director of Auburn university Research initiative in cancer